18-hydroxycorticosterone has been researched along with Pituitary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biglieri, EG; Brust, N; Chang, BC; Hirai, J; Kater, CE; Rost, CR; Schambelan, M | 1 |
1 other study(ies) available for 18-hydroxycorticosterone and Pituitary Neoplasms
Article | Year |
---|---|
The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
Topics: 18-Hydroxycorticosterone; Adenoma; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Child; Child, Preschool; Corticosterone; Cushing Syndrome; Cytochrome P-450 CYP11B2; Female; Humans; Hydrocortisone; Infant; Kidney Diseases; Male; Middle Aged; Mixed Function Oxygenases; Pituitary Diseases; Pituitary Neoplasms; Potassium; Renin; Renin-Angiotensin System | 1985 |